Bullish Case: WB at $6.735 sits below the $7.50 strike that dominates call open interest (Jan-2027 7.50C, IV 26.4%, active volume). Contango in the term structure and Helium's near-term IV band (62-69) converging to market levels by Jan (33 vs 29.4) imply the market sees the left-tail premium decaying. $2.6B cash, 1.6x book, and 561M MAU cap downside; even modest ad stabilization could re-rate WB toward $7.50-$8.00.

Bearish Case: WB is down 45% year-over-year and 7.6% over ninety days with persistent drift, not stabilization. Helium's Nov IV band (68.8) far exceeds market IV (39.4) — the model still prices fat left tails the market underweights. The historical return surface shows frequent -45% to -50% episodes at multi-month horizons. Options volume at the 2nd percentile means no buyer support; advertising decline and margin compression (26% vs 33%) remain unaddressed.

Potential Outcomes: 1) Rangebound $6.20–$7.30 (40%): flat price action, contango, and negligible volume persist through Nov expiry; falsified if WB closes >$7.50 twice.
2) Drift lower to $5.50–$6.20 (30%): ad erosion continues; falsified if low-strike put IV premium compresses rather than widens.
3) Recovery to $7.50–$8.40 (18%): Q3 earnings beat or VAS acceleration; falsified if Helium-vs-market Nov IV gap (68.8 vs 39.4) widens.
4) Crash below $5.50 (12%): China regulatory/ad shock; would flip term structure to backwardation with deep-OTM put IVs spiking toward the 200-400 range seen in Oct/Nov $2.50 strikes.

September 22, 2026